Oxygen therapeutics biotech NuvOx filed for a $20 million IPO on NYSE American, pricing 2.86 million shares at $6 to $8 each as it advances its platform for treating hypoxia and tissue damage.
Source: SEC filing
Picture a couple in their early sixties. He spent 35 years in a higher-paying career. She stepped in and out of work to raise kids and care for aging parents, so her earnings record is thinner. They are both healthy, the mortgage is nearly gone, and they have enough in savings t…
Coca-Cola's rare 4.6% intraday slide is catching attention in a stock that typically trades like clockwork, signaling something shifted today for the consumer staples benchmark.
Lucid Group surged as traders pounced on the EV maker after its early-session dip.
SpaceX shares are cratering after a scrubbed Starship test flight, and a niche leveraged ETF is turning that pain into outsized gains for short-sellers who knew exactly where to position themselves.
Netflix bounced 5.7% off the open as traders rotated back into the streaming giant after recent selloff fears cooled.
WaFd cleared both top and bottom line estimates as active loan portfolios grew 10.4% annualized and the bank squeezed its efficiency ratio to 53.7%, signaling disciplined expense management. CEO Brent Beardall flagged 15% year-over-year EPS growth and a 11% return on tangible common equity, while the stock is up 19% since March.
311 companies report this week with AMC and Domino's kicking off Monday, a deluge that spans retail demand, banks, and industrial output across five trading days.
Jim Cramer says AI shocks like DeepSeek are not a one-time event but a permanent feature of the market, and the cybersecurity stocks positioned to profit from every future wave are already moving fast enough to leave most investors behind.
Karooooo is paying out $46.3 million to shareholders this month, topping a digest of 50 dividend announcements with ex-date today. WD-40 and McGrath RentCorp also cutting checks by month's end.
Ramsey pushes back on the impulse to overspend on kids to match peers, warning that sacrificing your financial plan isn't worth the comparison trap.
It is hard to watch other families give their kids things you can't afford and wonder if your children are falling behind. But you don't have to go into debt, pause the Baby Steps or sacrifice your family's financial peace just to keep up. Your kids don't need the most https://t.co/6elQecp00t
Pain relief biotech Latigo filed to go public as non-opioid painkillers become the race to watch on Wall Street, backed by Goldman Sachs and Jefferies.
Source: SEC filing